SEC Form 4 · accession 0001161697-18-000302
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles B O'Keeffe
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 1, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Jun 1, 2018 | P | 5,000 | $3.736 | A | 518,376 | D |
Table II — derivative securities
No Table II lines on this filing.